Therapeutic hydroxyquinolones

US9701638B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9701638-B2
Application numberUS-201314441797-A
CountryUS
Kind codeB2
Filing dateNov 8, 2013
Priority dateNov 9, 2012
Publication dateJul 11, 2017
Grant dateJul 11, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention provides compounds of formula (I) and salts thereof wherein R 4 -R 8 have any of the meanings defined in the specification, as well as pharmaceutical compositions comprising the compounds or salts and methods for their use in therapy. The compounds have useful antiviral properties.

First claim

Opening claim text (preview).

What is claimed is: 1. A compound of formula (I): wherein: R 4 is: (C 4 -C 10 )alkanoyl; (C 1 -C 10 )alkyl that is substituted with one or more groups independently selected from cyano, halo, nitro, hydroxy, oxo, aryl, heteroaryl, heterocycle, aryloxy, heteroaryloxy, heterocycleoxy-, —NR e R f , —S(O) n R g , —N(R y )S(O) n R g , —S(O) n NR e R f , and —CONR e R f ; wherein each heterocycle of R m is optionally substituted with one or more groups independently selected from (C 1 -C 6 )alkyl, halo(C 1 -C 6 )alkyl, (C 2 -C 6 )alkenyl, (C 2 -C 6 )alkynyl, (C 1 -C 6 )alkoxy, (C 3 -C 12 )carbocycle, cyano, halo, nitro, hydroxy, oxo, carboxy, aryloxy, heteroaryloxy, heterocycleoxy, —NR e R f , —S(O) n R g , —N(R y )S(O) n R g , —COOR g , and —CONR e R f ; wherein each aryl and heteroaryl of R m is optionally substituted with one or more groups independently selected from (C 1 -C 6 )alkyl, halo(C 1 -C 6 )alkyl, (C 2 -C 6 )alkenyl, (C 2 -C 6 )alkynyl, (C 1 -C 6 )alkoxy, (C 3 -C 12 )carbocycle, cyano, halo, nitro, hydroxy, carboxy, aryl, heteroaryl, aryloxy, heteroaryloxy, heterocycleoxy, —NR e R f , —S(O) n R g , —N(R y )S(O) n R g , —S(O) n NR e R f , —COOR g , and —CONR e R f ; wherein each each R g is independently selected from (C 1 -C 6 )alkyl, (C 1 -C 6 )alkanoyl, aryl(C 1 -C 6 )alkyl, heteroaryl(C 1 -C 6 )alkyl, (C 3 -C 12 )carbocycle, aryl, and heteroaryl; or (C 1 -C 10 )alkanoyl that is substituted with one or more groups independently selected from cyano, halo, nitro, hydroxy, oxo, aryl, heteroaryl, heterocycle, aryloxy, heteroaryloxy, heterocycleoxy-, —S(O) n R g , —N(R y )S(O) n R g , —S(O) n NR e R f , and —CONR e R f ; wherein each heterocycle of R m is optionally substituted with one or more groups independently selected from (C 1 -C 6 )alkyl, halo(C 1 -C 6 )alkyl, (C 2 -C 6 )alkenyl, (C 2 -C 6 )alkynyl, (C 1 -C 6 )alkoxy, (C 3 -C 12 )carbocycle, cyano, halo, nitro, hydroxy, oxo, carboxy, aryloxy, heteroaryloxy, heterocycleoxy, —NR e R f , —S(O) n R g , —N(R y )S(O) n R g , —COOR g , and —CONR e R f ; wherein each aryl and heteroaryl of R m is optionally substituted with one or more groups independently selected from (C 1 -C 6 )alkyl, halo(C 1 -C 6 )alkyl, (C 2 -C 6 )alkenyl, (C 2 -C 6 )alkynyl, (C 1 -C 6 )alkoxy, (C 3 -C 12 )carbocycle, cyano, halo, nitro, hydroxy, carboxy, aryl, heteroaryl, aryloxy, heteroaryloxy, heterocycleoxy, —NR e R f , —S(O) n R g , —N(R y )S(O) n R g , —S(O) n NR e R f , —COOR g , and —CONR e R f ; wherein each each R g is independently selected from hydrogen, (C 1 -C 6 )alkyl, (C 1 -C 6 )alkanoyl, aryl(C 1 -C 6 )alkyl, heteroaryl(C 1 -C 6 )alkyl, (C 3 -C 12 )carbocycle, aryl, and heteroaryl; R 5 is H, halo, (C 1 -C 10 )alkyl, (C 2 -C 10 )alkenyl, (C 2 -C 10 )alkynyl, (C 1 -C 10 )alkoxy, (C 3 -C 12 )carbocycle, —NR e R f , —COOR g , cyano, nitro, aryl, heteroaryl, or (C 1 -C 10 )alkanoyl, wherein each (C 1 -C 10 )alkyl, (C 2 -C 10 )alkenyl, (C 2 -C 10 )alkynyl, (C 1 -C 10 )alkoxy, (C 3 -C 12 )carbocycle, and (C 1 -C 10 )alkanoyl are optionally substituted with one or more groups independently selected from R m ; and wherein each aryl and heteroaryl is optionally substituted with one or more groups independently selected from R n ; R 6 is H, halo, (C 1 -C 10 )alkyl, (C 2 -C 10 )alkenyl, (C 2 -C 10 )alkynyl, (C 1 -C 10 )alkoxy, (C 3 -C 12 carbocycle, —NR e R f , —COOR g , cyano, nitro, aryl, heteroaryl, or (C 1 -C 6 )alkanoyl, wherein each (C 1 -C 10 )alkyl, (C 2 -C 10 )alkenyl, (C 2 -C 10 )alkynyl, (C 1 -C 10 )alkoxy, (C 3 -C 12 )carbocycle, and (C 1 -C 10 )alkanoyl are optionally substituted with one or more groups independently selected from R m ; and wherein each aryl and heteroaryl is optionally substituted with one or more groups independently selected from R n ; R 7 is H, halo, (C 1 -C 10 )alkyl, (C 2 -C 10 )alkenyl, (C 2 -C 10 )alkynyl, (C 1 -C 10 )alkoxy, (C 3 -C 12 )carbocycle, —NR e R f , —COOR g , cyano, nitro, aryl, heteroaryl, or (C 1 -C 10 )alkanoyl, wherein each (C 1 -C 10 )alkyl, (C 2 -C 10 )alkenyl, (C 2 -C 10 )alkynyl, (C 1 -C 10 )alkoxy, (C 3 -C 12 )carbocycle, and (C 1 -C 10 )alkanoyl are optionally substituted with one or more groups independently selected from R m ; and wherein each aryl and heteroaryl is optionally substituted with one or more groups independently selected from R n ; R 8 is H, halo, (C 1 -C 10 )alkyl, (C 2 -C 10 )alkenyl, (C 2 -C 10 )alkynyl, (C 1 -C 10 )alkoxy, (C 3 -C 12 )carbocycle, —NR e R f , —COOR g , cyano, nitro, aryl or (C 1 -C 10 )alkanoyl, (C 1 -C 10 )alkyl, (C 2 -C 10 )alkenyl, (C 2 -C 10 )alkynyl, (C 1 -C 10 )alkoxy, (C 3 -C 12 )carbocycle, and (C 1 -C 10 )alkanoyl are optionally substituted with one or more groups independently selected from R m ; and wherein each aryl is optionally substituted with one or more groups independently selected from R n ; each R e and R f is independently selected from hydrogen, (C 1 -C 6 )alkyl, (C 1 -C 6 )alkanoyl, aryl(C 1 -C 6 )alkyl, heteroaryl(C 1 -C 6 )alkyl, (C 3 -C 12 )carbocycle, aryl, and heteroaryl; or R e and R f together with the nitrogen to which they are attached form a aziridino, azetidino, morpholino, piperazino, pyrrolidino or piperidino; each R g is independently selected from hydrogen, (C 1 -C 6 )alkyl, (C 1 -C 6 )alkanoyl, aryl(C 1 -C 6 )alkyl, heteroaryl(C 1 -C 6 )alkyl, (C 3 -C 12 )carbocycle, aryl, and heteroaryl; each R m is independently selected from cyano, halo, nitro, hydroxy, oxo, aryl, heteroaryl, heterocycle, aryloxy, heteroaryloxy, heterocycleoxy-, —NR e R f , —S(O) n R g , —N(R y )S(O) n R g , —S(O) n NR e R f , —COOR g , and —CONR e R f ; wherein each heterocycle of R m is optionally substituted with one or more groups independently selected from (C 1 -C 6 )alkyl, halo(C 1 -C 6 )alkyl, (C 2 -C 6 )alkenyl, (C 2 -C 6 )alkynyl, (C 1 -C 6 )alkoxy, (C 3 -C 12 )carbocycle, cyano, halo, nitro, hydroxy, oxo, carboxy, aryloxy, heteroaryloxy, heterocycleoxy, —NR e R f , —S(O) n R g , —N(R y )S(O) n R g , —COOR g , and —CONR e R f ; wherein each aryl and heteroaryl of R m is optionally substituted with one or more groups independently selected from (C 1 -C 6 )alkyl, halo(C 1 -C 6 )alkyl, (C 2 -C 6 )alkenyl, (C 2 -C 6 )alkynyl, (C 1 -C 6 )alkoxy, (C 3 -C 12 )carbocycle, cyano, halo, nitro, hydroxy, carboxy, aryl, heteroaryl, aryloxy, heteroaryloxy, heterocycleoxy, —NR e R f , —S(O) n R g , —N(R y )S(O) n R g , —S(O) n NR e R f , —COOR g , and —CONR e R f ; each R n independently selected from C 1 -C 6 )alkyl, (C 2 -C 6 )alkenyl, (C 2 -C 6 )alkynyl, (C 1 -C 6 )alkoxy, (C 3 -C 12 )carbocycle, aryl, heteroaryl, heterocycle, cyano, halo, nitro, hydroxy, carboxy, aryloxy, heteroaryloxy, heterocycleoxy, —NR e R f , —S(O) n R g , —N(R y )S(O) n R g , —S(O) n NR e R f , —COOR g , and —CONR e R f ; wherein each (C 1 -C 6 )alkyl, (C 2 -C 6 )alkenyl, (C 2 -C 6 )alkynyl, (C 1 -C 6 )alkoxy, heterocycle, and (C 3 -C 12 )carbocycle of R n is optionally substituted with one or more groups independently selected from cyano, halo, nitro, hydroxy, carboxy, heteroaryl, aryloxy, heteroaryloxy, heterocycleoxy, —NR e R f , —S(O) n R g , —N(R y )S(O) n R g , —COOR g , and —CONR e R f ; wherein each aryl and heteroaryl of R n is optionally substituted with one or more groups independently selected from (C 1 -C 6 )alkyl, halo(C 1 -C 6 )alkyl, (C 2 -C 6 )alkenyl, (C 2 -C 6 )alkynyl, (C 1 -C 6 )alkoxy, (C 3 -C 12 )carbocycle, cyano, halo, nitro, hydroxy, aryl, heteroaryl, aryloxy, heteroaryloxy, heterocycleoxy, —NR e R f , —S(O) n R g , —N(R y )S(O) n R g , —COOR g , —S(O) n NR e R f , and —CONR e R f ; each R y is independently selected from hydrogen and (C 1 -C 6 )alkyl; and n is 0, 1, or 2; or a salt thereof. 2. A compound of formula (I):

Assignees

Inventors

Classifications

  • linked by a carbon chain containing aromatic rings · CPC title

  • for HIV · CPC title

  • directly linked by a ring-member-to-ring-member bond · CPC title

  • containing three or more hetero rings · CPC title

  • only one oxygen atom which is attached in position 2 · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9701638B2 cover?
The invention provides compounds of formula (I) and salts thereof wherein R 4 -R 8 have any of the meanings defined in the specification, as well as pharmaceutical compositions comprising the compounds or salts and methods for their use in therapy. The compounds have useful antiviral properties.
Who is the assignee on this patent?
Univ Rutgers
What technology area does this patent fall under?
Primary CPC classification C07D215/22. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jul 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).